From my perspective and IMO, Where are we going? What is

New Post Public Reply Private Reply Replies (4) Message Board
MGK_2
717
From my perspective and IMO, Where are we going? What is all this leading to?
When Amarex begins to draw to a close, to a conclusion, some of Big Pharma will become more comfortable with CytoDyn, with Leronlimab. Big Money like Blackrock and Vanguard becomes more comfortable with going long CYDY and not so head long on shorting it. Big Media begin producing pro-CYDY articles and report factual, non-distortive information on CytoDyn and Leronlimab. The FDA approves Leronlimab.



When Amarex resolves, the FDA is comfortable with CytoDyn and many Big Pharma approach CytoDyn wanting to partner. They see Leronlimab's capacity to augment the functionality of their drug and ask CytoDyn to consider combination therapy for their indication. This becomes Big Pharma's only chance in escalating their drugs to the next level in the new era of enlightenment. Otherwise, they fail. Partnership with CytoDyn, in combination therapy with Leronlimab becomes their saving grace.

//

Given that Amarex is arbitration, it shouldn't go on for years. I'm giving it about a year from when it began, to about November or December, 2022. But it is very complicated. I don't know how deep Sidley Austin wants to take this. I don't know how much of a settlement they will be happy with. I don't know how easy are the pickins. I don't feel they will be happy with settling for less than a billion, so they may drag it on until they can get that, but I don't think they will continue to pursue the matter so long to extract its full worth of probably $20 billion.

So far so good. No discussion that arbitration is off course, therefore, I put it on course. Justice must be done. Judgement is coming. SA won't stop till justice comes to pass. The conclusion of the Amarex arbitration brings about a new era in pharmaceutical therapy, LL approval, FDA clearance and multiple BP partnerships in combination with Leronlimab.

//

What is Justice? Who did wrong? Was it only Amarex? Who collaborated with them? Will another pharmaceutical be implicated? Will Big Money be implicated? Will anyone rat on the other? Will anyone stand for CytoDyn? Will anyone agree that the BLA was sabotaged? Will anyone testify that the trials were botched or poorly documented? Will anyone bring about these details and clearly reveal what actually happened? Will the outcome of the Amarex arbitration set the record straight? What will be the main outcome after this arbitration is resolved? Would it be to reveal that Amarex was a pitiful CRO who couldn't write a BLA to save its life? (I think not.) or Would it be to reveal how a certain Pharma or a group of Pharmaceuticals and/or Big Money fear the FDA approval of Leronlimab given a successful combination trial of LL with HAART for HIV, with a p value of 0.0032.

From Wiki:
Quote:
In the pivotal trial of Leronlimab in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients, 81% of patients completing trial achieved HIV viral load suppression of < 50 cp/mL. (where as ONLY with) Recent approved drugs for this population range from ONLY 43% after 24 weeks to ONLY 45% after 48 weeks with viral load suppression of < 50 cp/mL.


CytoDyn knew they had this in the bag. Everything had been lined up. Manufacturing. Salesforce. Distribution. Even Amarex said they will have the BLA submitted on time.

The only way this Big Entity had to block the approval of LL was to trip up the third part of this BLA submission and how else to do that but by sabotaging the BLA by colluding with the entity writing the Document who was the CRO, Amarex. How did they get the CRO/Amarex to submit a pathetic and cringeworthy document?

All of this is what Sidley Austin is set out to determine. How long will this drag out? What are the consequences if these multiple factions and entities do not oblige Sidley Austin? Delays and delays and it depends on the interactions between the entities involved. Some will push to get this resolved. I feel it will finish near end of year 2022.

Who put up the necessary $6.5 million bond to carry this arbitration out? David Welch put up this bond, out of his confidence and conviction in the matter. Whoever or whatever group/entity it was that colluded with Amarex to commit this deed against us, it should always be remembered that it was David Welch that has prevented this entity from doing it to us again, because, it will never happen again as a result of this arbitration which he stood for.

//

The addition of Dr. Paul Edison, Dr. Kabir Mody, Dr. Otto Yang and Dr. Jacob Lalazari, which potential CEO candidate would not be proud of such a list of experts to help him make his decisions? Doesn't the addition of this team of experts facilitate the search for an experienced and qualified CEO?

What if Amarex arbitration conclusion and the new CEO come together? I already said FDA comfort zone comes with Amarex concluding and then compounding that with a new qualified CEO... what do you have? CytoDyn grows big because many Big Pharma will have no chance without LL. Who ever is not against us is for us. Many will choose to join us. Yet, many will choose to fight this war with old tactics of deceit and usury, paying off the approving party for rapid approval, using inept, sub-par weapons of partial effectiveness, using all they and whatever they have and whoever would help them to beat us, still yet employing big money & big media but proving futile; however, many will leave those tactics and will rather choose a better way, leading to their success and to ours. Yes, the battles will continue.

//

You will have no need to be told that the times for CytoDyn have changed. It will be crystal clear. With the ending of Amarex and the completion of our board with new CEO, a new era begins in pharmaceutical treatments. A revelation will come over the people of the massive deceit which goes on in this industry. An understanding of the corruption and greed will grow. Clear evidence of clean effectual medicine being purposely thwarted and hindered pervades the atmosphere, the air waves. Understanding of disease pathways and mechanism of actions that confuse and render those diseases as inconsequential becomes paramount. People will wake the flapjacks up, people will become wiser. You will see this happen. Many companies are persuaded and pursue the ways of the people. They begin to pursue this new found understanding. But, many will hold fast to the old ways. But a division will be clear as day. A new age approaches and I feel humanity will survive it with CytoDyn leading, while Big Pharma and all of the other Bigs wither away, diminishing in battle.

1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 2

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 3

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
BusyBee AI Revolutionizes Classroom Feedback Efficiency

Updated Category News Views 3

Grading Overhaul: BusyBee's Role in Education Here's a twist for the history books: Agilix Labs' BusyBee, a slick AI assistant built right into the Buzz platform on Amazon Bedrock, is kicking traditional grading methods to the curb. This little helper is grading close to a million K-12 student submissions every month, meticulously approved by real teachers. Quite the...

Continue Reading
Insurance Bad Faith: Navigating California's Rigorous Laws

Updated Category News Views 4

Understanding What Constitutes Bad Faith Insurance What does it really mean when an insurer acts in "bad faith"? Well, the legal standard doesn't leave much wiggle room in California. These aren't just bad outcomes; we're talking about conduct that defies what's reasonable under state law. Demián I. Oksenendler, a seasoned bad faith attorney, shed some light on this in a...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 5

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading
SES Sells to AFC Industries: A Strategic M&A Move

Updated Category News Views 3

Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...

Continue Reading
Red-Eye Flights Surge, Driven By Western U.S. Routes

Updated Category News Views 5

You can always count on some things staying the same, right? Well, if you thought red-eye flights were going to fade away, think again. These late-night wonders are not just hanging around—they're booming in the west like there's no tomorrow. Literally. Champion Traveler has laid it all out for us: about 115,580 overnight flights in 2025, a record high since this mad...

Continue Reading
World Fire Congress 2026 Champions Global Fire Safety

Updated Category News Views 3

Rethinking Fire Safety with a Global Mindset The 2026 World Fire Congress wrapped up in London, signaling a big shift in how we tackle fire safety. Over 60 nations were represented, and they all walked away singing the same tune: if we’re going to handle these ever-mounting fire risks, we have to lean on each other a lot more. Next stop on this crusade? The flashy city...

Continue Reading
Albertsons Welcomes Once Upon a Coconut Nationwide

Updated Category News Views 4

Coconut Water Takes Over Grocery Aisles You know, for all the cautious optimism I wield, this here is a move that shows real muscle in the world of coconut water—I mean, slamming into Albertsons' grocery empire is no small potatoes! Once Upon a Coconut has landed its premium hydration cans across all the banners under this giant retailer. From that good ol' familiar...

Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport

Updated Category News Views 2

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Continue Reading

Top 5 Most Recently Viewed Articles

Human-I-T Launches Certification to Promote Responsible Tech Use

Updated Category News Views 322

Human-I-T Introduces a Groundbreaking Certification Human-I-T, a frontrunner in promoting digital equity and sustainable refurbishment of electronic devices, has announced its new program: the Responsible Tech Management Certification. This initiative aims to set a high bar for data destruction by recognizing organizations that meet the rigorous standards of compliance,...

Continue Reading
Dalan Animal Health Unveils Groundbreaking Vaccine for Honeybees

Updated Category News Views 192

Innovative Solutions for Honeybee Conservation Dalan Animal Health, Inc. has emerged as a leading force in addressing the critical crisis facing honeybee populations. As beekeepers across the nation report monumental losses, Dalan's innovative vaccine technology could provide the necessary support to reverse the disturbing trends impacting these essential pollinators. The...

Continue Reading
Nykredit Realkredit A/S Announces New Coupon Rates Update

Updated Category News Views 107

New Coupon Rates Adjustment for Floating-Rate Bonds Nykredit Realkredit A/S is set to adjust the coupon rates of its floating-rate bonds effective from April 1, 2025. This change will influence several bonds with varying maturities and is crucial for investors to note. Effective Date and Details The adjusted coupon rates will be applicable from April 1, 2025, extending...

Continue Reading
Valero Extends Partnership with Texas Super Kings To 2028

Updated Category News Views 8

Renewing Ties in Texas Cricket Well, look at that—the Texas Super Kings and Valero just locked in another two years together through 2028. If you thought sports and business were going their separate ways, this partnership glues them together with more vigor than a rookie trying to hit a home run. Both are Texas-rooted, sharing values like performance and innovation, so...

Continue Reading
JPMorgan Asset Management's Major Stake in OSB Group Plc

Updated Category News Views 109

Understanding Major Holdings in OSB Group Plc Major shareholding notifications are vital for investors and stakeholders as they shed light on the dynamics of ownership and influence within a company. Recently, JPMorgan Asset Management Holdings Inc. has crossed significant thresholds in its holding in OSB Group Plc, revealing important insights into its investment...

Continue Reading